[HTML][HTML] Three-year results of the VIBRANT trial of VIABAHN endoprosthesis versus bare nitinol stent implantation for complex superficial femoral artery occlusive …

PJ Geraghty, MW Mewissen, MR Jaff, GM Ansel… - Journal of vascular …, 2013 - Elsevier
Objective The predominant mode of bare nitinol stent failure is diffuse in-stent restenosis,
and failure rates correlate to the length and complexity of the treated lesion. Addition of an …

[引用][C] Three-year results of the VIBRANT trial of VIABAHN endoprosthesis versus bare nitinol stent implantation for complex superficial femoral artery occlusive …

PJ Geraghty, MW Mewissen… - Journal of Vascular …, 2013 - espace.library.uq.edu.au
Objective: The predominant mode of bare nitinol stent failure is diffuse in-stent restenosis,
and failure rates correlate to the length and complexity of the treated lesion. Addition of an …

[PDF][PDF] Three-year results of the VIBRANT trial of VIABAHN endoprosthesis versus bare nitinol stent implantation for complex superficial femoral artery occlusive …

PJ Geraghty, MW Mewissen, MR Jaff… - JOURNAL OF VASCULAR …, 2013 - core.ac.uk
Objective: The predominant mode of bare nitinol stent failure is diffuse in-stent restenosis,
and failure rates correlate to the length and complexity of the treated lesion. Addition of an …

Three-year results of the VIBRANT trial of VIABAHN endoprosthesis versus bare nitinol stent implantation for complex superficial femoral artery occlusive disease

PJ Geraghty, MW Mewissen, MR Jaff… - Journal of Vascular …, 2013 - jvascsurg.org
Objective The predominant mode of bare nitinol stent failure is diffuse in-stent restenosis,
and failure rates correlate to the length and complexity of the treated lesion. Addition of an …

Three-year results of the VIBRANT trial of VIABAHN endoprosthesis versus bare nitinol stent implantation for complex superficial femoral artery occlusive disease

PJ Geraghty, MW Mewissen, MR Jaff… - Journal of Vascular …, 2013 - profiles.wustl.edu
Objective: The predominant mode of bare nitinol stent failure is diffuse in-stent restenosis,
and failure rates correlate to the length and complexity of the treated lesion. Addition of an …

Three-year results of the VIBRANT trial of VIABAHN endoprosthesis versus bare nitinol stent implantation for complex superficial femoral artery occlusive disease.

PJ Geraghty, MW Mewissen, MR Jaff… - Journal of Vascular …, 2013 - europepmc.org
Objective The predominant mode of bare nitinol stent failure is diffuse in-stent restenosis,
and failure rates correlate to the length and complexity of the treated lesion. Addition of an …

Three-year results of the VIBRANT trial of VIABAHN endoprosthesis versus bare nitinol stent implantation for complex superficial femoral artery occlusive disease

PJ Geraghty, MW Mewissen, MR Jaff… - Journal of Vascular …, 2013 - infona.pl
The predominant mode of bare nitinol stent failure is diffuse in-stent restenosis, and failure
rates correlate to the length and complexity of the treated lesion. Addition of an expanded …

Three-year results of the VIBRANT trial of VIABAHN endoprosthesis versus bare nitinol stent implantation for complex superficial femoral artery occlusive disease

PJ Geraghty, MW Mewissen, MR Jaff, GM Ansel… - 2013 - pubmed.ncbi.nlm.nih.gov
Objective The predominant mode of bare nitinol stent failure is diffuse in-stent restenosis,
and failure rates correlate to the length and complexity of the treated lesion. Addition of an …

Three-year results of the VIBRANT trial of VIABAHN endoprosthesis versus bare nitinol stent implantation for complex superficial femoral artery occlusive disease

PJ Geraghty, MW Mewissen, MR Jaff… - Journal of Vascular …, 2013 - hero.epa.gov
Objective: The predominant mode of bare nitinol stent failure is diffuse in-stent restenosis,
and failure rates correlate to the length and complexity of the treated lesion. Addition of an …

[引用][C] Three-year results of the VIBRANT trial of VIABAHN endoprosthesis versus bare nitinol stent implantation for complex superficial femoral artery occlusive …

PJ Geraghty, MW Mewissen, MR Jaff… - Journal of Vascular …, 2013 - cir.nii.ac.jp
Three-year results of the VIBRANT trial of VIABAHN endoprosthesis versus bare nitinol stent
implantation for complex superficial femoral artery occlusive disease | CiNii Research CiNii …